Interbody Fusion Cage Market by Product Type (Lumbar Cage, Cervical Cage, Thoraco-lumbar Cage, and Thoracic Cage), Surgery (Anterior, Posterior, Lateral, and Transforaminal), and End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others) : Global Opportunity Analysis and Industry Forecast, 2021-2030
The global interbody fusion cages market was valued at $ 1,901.67 million in 2020, and is projected to reach $ 3,012.47 million by 2030, registering a CAGR of 4.7% from 2021 to 2030.
Interbody fusion cage is an artificial medical device, which is utilized in spinal fusion procedures to maintain foraminal height and decompression. The interbody fusion cage is a large, hollow cylinder made up of metals such as titanium, carbon fiber, or allograft femur. The device is designed as a cage so that bone graft can be placed inside the hollow cylinder to allow a spinal fusion to occur between two vertebrae. Interbody fusion cage utilized to provide stability to the spine and the cervical region. The cages can be filled with autologous bone material to promote arthrodesis (artificial induction of joint ossification).
The key factors that drive the market growth are rise in geriatric population and increase in spinal cord injuries, which might be caused due to accidents and diseases such as degenerative disk disease. However, high cost associated with spinal fusion surgeries and dearth of skilled professionals are anticipated to impede the growth of interbody fusion cage market. On the contrary, increased adoption of minimally invasive surgeries is projected to create ample opportunities in the market.
The interbody fusion cages market is segmented into product type, surgery, end user, and region. By product type, the market is segregated into lumbar cage, cervical cage, thoraco-lumbar cage, and thoracic cage. On the basis of surgery, it is fragmented into anterior, posterior, lateral, and transforaminal. Depending on end user, it is fragmented into hospitals & clinics, ambulatory surgical centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA).
The major companies profiled in the report include Aurora Spine, Inc, B. Braun Melsungen AG, Benvenue Medical Inc., Prodorth, Ulrich Medicals, Orthofix, Medtronic Plc., Zimmer Biomet Holdings, Inc., NuVasive, Inc., and Johnson & Johnson.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the global interbody fusion cage market with current trends and future estimations to elucidate the imminent investment pockets.
Comprehensive quantitative analysis of the industry from 2021 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the key segments of the industry helps to understand the products and technologies used globally.
Key market players and their strategies are provided to understand the competitive outlook of the market
By Product Type
Lumbar Cage
Cervical Cage
Thoraco-lumbar Cage
Thoracic Cage
By Surgery
Anterior
Posterior
Lateral
Transforaminal
By End user
Hospital & Clinics
Others
Ambulatory Surgical Center
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
KEY Players
AstraZeneca PLC
Bristol-Myers Squibb Company
Boehringer Ingelheim
GNI Group Ltd
F. Hoffmann-La Roche Ltd. (Genentech, Inc.,)
Shiongi co Ltd
Mission Therapeutics
Biogen, Inc
Galapagos NV
FibroGen, Inc
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1.CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1.Market Definition and Scope
- 3.2.Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3.Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Share Analysis/Top Player Positioning
- 3.4.1. Market Share Analysis/Top Player Positioning 2020
- 3.5. Market Dynamics
- 3.5.1. Drivers
- 3.5.2. Restraints
- 3.5.3. Opportunities
- 3.6. COVID-19 Impact Analysis
- CHAPTER 4: INTERBODY FUSION CAGES MARKET, BY PRODUCT
- 4.1. Market Overview
- 4.1.1Market Size and Forecast, By Product
- 4.2. Lumbar
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Cervical
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- 4.4. Thoraco Lumbar
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country
- 4.5. Thoracic
- 4.5.1. Key Market Trends, Growth Factors and Opportunities
- 4.5.2. Market Size and Forecast, By Region
- 4.5.3. Market Share Analysis, By Country
- CHAPTER 5: INTERBODY FUSION CAGES MARKET, BY SURGERY
- 5.1. Market Overview
- 5.1.1Market Size and Forecast, By Surgery
- 5.2. Anterior
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Transforaminal
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- 5.4. Posterior
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
- 5.5. Lateral
- 5.5.1. Key Market Trends, Growth Factors and Opportunities
- 5.5.2. Market Size and Forecast, By Region
- 5.5.3. Market Share Analysis, By Country
- CHAPTER 6: INTERBODY FUSION CAGES MARKET, BY END USER
- 6.1. Market Overview
- 6.1.1Market Size and Forecast, By End User
- 6.2. Hospitals And Clinics
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
- 6.3. Ambulatory Surgical Centers
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
- 6.4. Others
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
- CHAPTER 7: INTERBODY FUSION CAGES MARKET, BY REGION
- 7.1. Market Overview
- 7.1.1Market Size and Forecast, By Region
- 7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Product
- 7.2.3. Market Size and Forecast, By Surgery
- 7.2.4. Market Size and Forecast, By End User
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.s. Interbody Fusion CAGES Market
- 7.2.6.1. Market Size and Forecast, By Product
- 7.2.6.2. Market Size and Forecast, By Surgery
- 7.2.6.3. Market Size and Forecast, By End User
- 7.2.7. Canada Interbody Fusion CAGES Market
- 7.2.7.1. Market Size and Forecast, By Product
- 7.2.7.2. Market Size and Forecast, By Surgery
- 7.2.7.3. Market Size and Forecast, By End User
- 7.2.8. Mexico Interbody Fusion CAGES Market
- 7.2.8.1. Market Size and Forecast, By Product
- 7.2.8.2. Market Size and Forecast, By Surgery
- 7.2.8.3. Market Size and Forecast, By End User
- 7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Product
- 7.3.3. Market Size and Forecast, By Surgery
- 7.3.4. Market Size and Forecast, By End User
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. Germany Interbody Fusion CAGES Market
- 7.3.6.1. Market Size and Forecast, By Product
- 7.3.6.2. Market Size and Forecast, By Surgery
- 7.3.6.3. Market Size and Forecast, By End User
- 7.3.7. France Interbody Fusion CAGES Market
- 7.3.7.1. Market Size and Forecast, By Product
- 7.3.7.2. Market Size and Forecast, By Surgery
- 7.3.7.3. Market Size and Forecast, By End User
- 7.3.8. Uk Interbody Fusion CAGES Market
- 7.3.8.1. Market Size and Forecast, By Product
- 7.3.8.2. Market Size and Forecast, By Surgery
- 7.3.8.3. Market Size and Forecast, By End User
- 7.3.9. Italy Interbody Fusion CAGES Market
- 7.3.9.1. Market Size and Forecast, By Product
- 7.3.9.2. Market Size and Forecast, By Surgery
- 7.3.9.3. Market Size and Forecast, By End User
- 7.3.10. Spain Interbody Fusion CAGES Market
- 7.3.10.1. Market Size and Forecast, By Product
- 7.3.10.2. Market Size and Forecast, By Surgery
- 7.3.10.3. Market Size and Forecast, By End User
- 7.3.11. Rest Of Europe Interbody Fusion CAGES Market
- 7.3.11.1. Market Size and Forecast, By Product
- 7.3.11.2. Market Size and Forecast, By Surgery
- 7.3.11.3. Market Size and Forecast, By End User
- 7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Product
- 7.4.3. Market Size and Forecast, By Surgery
- 7.4.4. Market Size and Forecast, By End User
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. Japan Interbody Fusion CAGES Market
- 7.4.6.1. Market Size and Forecast, By Product
- 7.4.6.2. Market Size and Forecast, By Surgery
- 7.4.6.3. Market Size and Forecast, By End User
- 7.4.7. China Interbody Fusion CAGES Market
- 7.4.7.1. Market Size and Forecast, By Product
- 7.4.7.2. Market Size and Forecast, By Surgery
- 7.4.7.3. Market Size and Forecast, By End User
- 7.4.8. Australia Interbody Fusion CAGES Market
- 7.4.8.1. Market Size and Forecast, By Product
- 7.4.8.2. Market Size and Forecast, By Surgery
- 7.4.8.3. Market Size and Forecast, By End User
- 7.4.9. India Interbody Fusion CAGES Market
- 7.4.9.1. Market Size and Forecast, By Product
- 7.4.9.2. Market Size and Forecast, By Surgery
- 7.4.9.3. Market Size and Forecast, By End User
- 7.4.10. South Korea Interbody Fusion CAGES Market
- 7.4.10.1. Market Size and Forecast, By Product
- 7.4.10.2. Market Size and Forecast, By Surgery
- 7.4.10.3. Market Size and Forecast, By End User
- 7.4.11. Rest of Asia Pacific Interbody Fusion CAGES Market
- 7.4.11.1. Market Size and Forecast, By Product
- 7.4.11.2. Market Size and Forecast, By Surgery
- 7.4.11.3. Market Size and Forecast, By End User
- 7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Product
- 7.5.3. Market Size and Forecast, By Surgery
- 7.5.4. Market Size and Forecast, By End User
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Interbody Fusion CAGES Market
- 7.5.6.1. Market Size and Forecast, By Product
- 7.5.6.2. Market Size and Forecast, By Surgery
- 7.5.6.3. Market Size and Forecast, By End User
- 7.5.7. South Africa, Interbody Fusion CAGES Market
- 7.5.7.1. Market Size and Forecast, By Product
- 7.5.7.2. Market Size and Forecast, By Surgery
- 7.5.7.3. Market Size and Forecast, By End User
- 7.5.8. Saudi Arabia Interbody Fusion CAGES Market
- 7.5.8.1. Market Size and Forecast, By Product
- 7.5.8.2. Market Size and Forecast, By Surgery
- 7.5.8.3. Market Size and Forecast, By End User
- 7.5.9. Rest of LAMEA Interbody Fusion CAGES Market
- 7.5.9.1. Market Size and Forecast, By Product
- 7.5.9.2. Market Size and Forecast, By Surgery
- 7.5.9.3. Market Size and Forecast, By End User
- CHAPTER 8: COMPANY PROFILES
- 8.1. Atom Medical Corporation
- 8.1.1. Company Overview
- 8.1.2. Key Executives
- 8.1.3. Company snapshot
- 8.1.4. Operating business segments
- 8.1.5. Product portfolio
- 8.1.6. Business Performance
- 8.1.7. Key Strategic Moves and Developments
- 8.2. AVI Healthcare Pvt. Ltd
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company snapshot
- 8.2.4. Operating business segments
- 8.2.5. Product portfolio
- 8.2.6. Business Performance
- 8.2.7. Key Strategic Moves and Developments
- 8.3. Equalize Heath, Inc
- 8.3.1. Company Overview
- 8.3.2. Key Executives
- 8.3.3. Company snapshot
- 8.3.4. Operating business segments
- 8.3.5. Product portfolio
- 8.3.6. Business Performance
- 8.3.7. Key Strategic Moves and Developments
- 8.4. GE Healthcare
- 8.4.1. Company Overview
- 8.4.2. Key Executives
- 8.4.3. Company snapshot
- 8.4.4. Operating business segments
- 8.4.5. Product portfolio
- 8.4.6. Business Performance
- 8.4.7. Key Strategic Moves and Developments
- 8.5. Ibis Medical Equipment And Systems Pvt. Ltd
- 8.5.1. Company Overview
- 8.5.2. Key Executives
- 8.5.3. Company snapshot
- 8.5.4. Operating business segments
- 8.5.5. Product portfolio
- 8.5.6. Business Performance
- 8.5.7. Key Strategic Moves and Developments
- 8.6. Natus Medical Incorporated
- 8.6.1. Company Overview
- 8.6.2. Key Executives
- 8.6.3. Company snapshot
- 8.6.4. Operating business segments
- 8.6.5. Product portfolio
- 8.6.6. Business Performance
- 8.6.7. Key Strategic Moves and Developments
- 8.7. Ningbo David Medical Device Co. Ltd
- 8.7.1. Company Overview
- 8.7.2. Key Executives
- 8.7.3. Company snapshot
- 8.7.4. Operating business segments
- 8.7.5. Product portfolio
- 8.7.6. Business Performance
- 8.7.7. Key Strategic Moves and Developments
- 8.8. Novos Medical Devices San. Tic. Imp. And Ihr. Ltd. Sti.
- 8.8.1. Company Overview
- 8.8.2. Key Executives
- 8.8.3. Company snapshot
- 8.8.4. Operating business segments
- 8.8.5. Product portfolio
- 8.8.6. Business Performance
- 8.8.7. Key Strategic Moves and Developments
- 8.9. Weyer GmbH
- 8.9.1. Company Overview
- 8.9.2. Key Executives
- 8.9.3. Company snapshot
- 8.9.4. Operating business segments
- 8.9.5. Product portfolio
- 8.9.6. Business Performance
- 8.9.7. Key Strategic Moves and Developments
- 8.10. Zhengzhou Dison Instrument And Meter Co. Ltd
- 8.10.1. Company Overview
- 8.10.2. Key Executives
- 8.10.3. Company snapshot
- 8.10.4. Operating business segments
- 8.10.5. Product portfolio
- 8.10.6. Business Performance
- 8.10.7. Key Strategic Moves and Developments
- LIST OF TABLES
- TABLE 1.GLOBAL INTERBODY FUSION CAGES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 2.GLOBAL INTERBODY FUSION CAGES MARKET FOR LUMBAR, BY REGION, 2020-2030 ($MILLION)
- TABLE 3.GLOBAL INTERBODY FUSION CAGES MARKET FOR CERVICAL, BY REGION, 2020-2030 ($MILLION)
- TABLE 4.GLOBAL INTERBODY FUSION CAGES MARKET FOR THORACO LUMBAR, BY REGION, 2020-2030 ($MILLION)
- TABLE 5.GLOBAL INTERBODY FUSION CAGES MARKET FOR THORACIC, BY REGION, 2020-2030 ($MILLION)
- TABLE 6.GLOBAL INTERBODY FUSION CAGES MARKET, BY SURGERY, 2020-2030 ($MILLION)
- TABLE 7.GLOBAL INTERBODY FUSION CAGES MARKET FOR ANTERIOR, BY REGION, 2020-2030 ($MILLION)
- TABLE 8.GLOBAL INTERBODY FUSION CAGES MARKET FOR TRANSFORAMINAL, BY REGION, 2020-2030 ($MILLION)
- TABLE 9.GLOBAL INTERBODY FUSION CAGES MARKET FOR POSTERIOR, BY REGION, 2020-2030 ($MILLION)
- TABLE 10.GLOBAL INTERBODY FUSION CAGES MARKET FOR LATERAL, BY REGION, 2020-2030 ($MILLION)
- TABLE 11.GLOBAL INTERBODY FUSION CAGES MARKET, BY END USER, 2020-2030 ($MILLION)
- TABLE 12.GLOBAL INTERBODY FUSION CAGES MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2020-2030 ($MILLION)
- TABLE 13.GLOBAL INTERBODY FUSION CAGES MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2020-2030 ($MILLION)
- TABLE 14.GLOBAL INTERBODY FUSION CAGES MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
- TABLE 15.GLOBAL INTERBODY FUSION CAGES MARKET, BY REGION, 2020-2030 ($MILLION)
- TABLE 16.NORTH AMERICA INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 17.NORTH AMERICA INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
- TABLE 18.NORTH AMERICA INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
- TABLE 19.U.S. INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 20.U.S. INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
- TABLE 21.U.S. INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
- TABLE 22.CANADA INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 23.CANADA INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
- TABLE 24.CANADA INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
- TABLE 25.MEXICO INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 26.MEXICO INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
- TABLE 27.MEXICO INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
- TABLE 28.EUROPE INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 29.EUROPE INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
- TABLE 30.EUROPE INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
- TABLE 31.GERMANY INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 32.GERMANY INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
- TABLE 33.GERMANY INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
- TABLE 34.FRANCE INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 35.FRANCE INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
- TABLE 36.FRANCE INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
- TABLE 37.UK INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 38.UK INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
- TABLE 39.UK INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
- TABLE 40.ITALY INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 41.ITALY INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
- TABLE 42.ITALY INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
- TABLE 43.SPAIN INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 44.SPAIN INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
- TABLE 45.SPAIN INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
- TABLE 46.REST OF EUROPE INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 47.REST OF EUROPE INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
- TABLE 48.REST OF EUROPE INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
- TABLE 49.ASIA-PACIFIC INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 50.ASIA-PACIFIC INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
- TABLE 51.ASIA-PACIFIC INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
- TABLE 52.JAPAN INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 53.JAPAN INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
- TABLE 54.JAPAN INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
- TABLE 55.CHINA INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 56.CHINA INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
- TABLE 57.CHINA INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
- TABLE 58.AUSTRALIA INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 59.AUSTRALIA INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
- TABLE 60.AUSTRALIA INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
- TABLE 61.INDIA INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 62.INDIA INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
- TABLE 63.INDIA INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
- TABLE 64.SOUTH KOREA INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 65.SOUTH KOREA INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
- TABLE 66.SOUTH KOREA INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
- TABLE 67.REST OF ASIA PACIFIC INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 68.REST OF ASIA PACIFIC INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
- TABLE 69.REST OF ASIA PACIFIC INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
- TABLE 70.LAMEA INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 71.LAMEA INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
- TABLE 72.LAMEA INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
- TABLE 73.BRAZIL INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 74.BRAZIL INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
- TABLE 75.BRAZIL INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
- TABLE 76.SOUTH AFRICA, INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 77.SOUTH AFRICA, INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
- TABLE 78.SOUTH AFRICA, INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
- TABLE 79.SAUDI ARABIA INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 80.SAUDI ARABIA INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
- TABLE 81.SAUDI ARABIA INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
- TABLE 82.REST OF LAMEA INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 83.REST OF LAMEA INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
- TABLE 84.REST OF LAMEA INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
- TABLE 85.ATOM MEDICAL CORPORATION: KEY EXECUTIVES
- TABLE 86.ATOM MEDICAL CORPORATION: COMPANY SNAPSHOT
- TABLE 87.ATOM MEDICAL CORPORATION: OPERATING SEGMENTS
- TABLE 88.ATOM MEDICAL CORPORATION: PRODUCT PORTFOLIO
- TABLE 89.ATOM MEDICAL CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 90.AVI HEALTHCARE PVT. LTD: KEY EXECUTIVES
- TABLE 91.AVI HEALTHCARE PVT. LTD: COMPANY SNAPSHOT
- TABLE 92.AVI HEALTHCARE PVT. LTD: OPERATING SEGMENTS
- TABLE 93.AVI HEALTHCARE PVT. LTD: PRODUCT PORTFOLIO
- TABLE 94.AVI HEALTHCARE PVT. LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 95.EQUALIZE HEATH, INC: KEY EXECUTIVES
- TABLE 96.EQUALIZE HEATH, INC: COMPANY SNAPSHOT
- TABLE 97.EQUALIZE HEATH, INC: OPERATING SEGMENTS
- TABLE 98.EQUALIZE HEATH, INC: PRODUCT PORTFOLIO
- TABLE 99.EQUALIZE HEATH, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 100.GE HEALTHCARE: KEY EXECUTIVES
- TABLE 101.GE HEALTHCARE: COMPANY SNAPSHOT
- TABLE 102.GE HEALTHCARE: OPERATING SEGMENTS
- TABLE 103.GE HEALTHCARE: PRODUCT PORTFOLIO
- TABLE 104.GE HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 105.IBIS MEDICAL EQUIPMENT AND SYSTEMS PVT. LTD: KEY EXECUTIVES
- TABLE 106.IBIS MEDICAL EQUIPMENT AND SYSTEMS PVT. LTD: COMPANY SNAPSHOT
- TABLE 107.IBIS MEDICAL EQUIPMENT AND SYSTEMS PVT. LTD: OPERATING SEGMENTS
- TABLE 108.IBIS MEDICAL EQUIPMENT AND SYSTEMS PVT. LTD: PRODUCT PORTFOLIO
- TABLE 109.IBIS MEDICAL EQUIPMENT AND SYSTEMS PVT. LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 110.NATUS MEDICAL INCORPORATED: KEY EXECUTIVES
- TABLE 111.NATUS MEDICAL INCORPORATED: COMPANY SNAPSHOT
- TABLE 112.NATUS MEDICAL INCORPORATED: OPERATING SEGMENTS
- TABLE 113.NATUS MEDICAL INCORPORATED: PRODUCT PORTFOLIO
- TABLE 114.NATUS MEDICAL INCORPORATED: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 115.NINGBO DAVID MEDICAL DEVICE CO. LTD: KEY EXECUTIVES
- TABLE 116.NINGBO DAVID MEDICAL DEVICE CO. LTD: COMPANY SNAPSHOT
- TABLE 117.NINGBO DAVID MEDICAL DEVICE CO. LTD: OPERATING SEGMENTS
- TABLE 118.NINGBO DAVID MEDICAL DEVICE CO. LTD: PRODUCT PORTFOLIO
- TABLE 119.NINGBO DAVID MEDICAL DEVICE CO. LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 120.NOVOS MEDICAL DEVICES SAN. TIC. IMP. AND IHR. LTD. STI.: KEY EXECUTIVES
- TABLE 121.NOVOS MEDICAL DEVICES SAN. TIC. IMP. AND IHR. LTD. STI.: COMPANY SNAPSHOT
- TABLE 122.NOVOS MEDICAL DEVICES SAN. TIC. IMP. AND IHR. LTD. STI.: OPERATING SEGMENTS
- TABLE 123.NOVOS MEDICAL DEVICES SAN. TIC. IMP. AND IHR. LTD. STI.: PRODUCT PORTFOLIO
- TABLE 124.NOVOS MEDICAL DEVICES SAN. TIC. IMP. AND IHR. LTD. STI.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 125.WEYER GMBH: KEY EXECUTIVES
- TABLE 126.WEYER GMBH: COMPANY SNAPSHOT
- TABLE 127.WEYER GMBH: OPERATING SEGMENTS
- TABLE 128.WEYER GMBH: PRODUCT PORTFOLIO
- TABLE 129.WEYER GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 130.ZHENGZHOU DISON INSTRUMENT AND METER CO. LTD: KEY EXECUTIVES
- TABLE 131.ZHENGZHOU DISON INSTRUMENT AND METER CO. LTD: COMPANY SNAPSHOT
- TABLE 132.ZHENGZHOU DISON INSTRUMENT AND METER CO. LTD: OPERATING SEGMENTS
- TABLE 133.ZHENGZHOU DISON INSTRUMENT AND METER CO. LTD: PRODUCT PORTFOLIO
- TABLE 134.ZHENGZHOU DISON INSTRUMENT AND METER CO. LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
- LIST OF FIGURES
- FIGURE 1.GLOBAL INTERBODY FUSION CAGES MARKET SEGMENTATION
- FIGURE 2.GLOBAL INTERBODY FUSION CAGES MARKET
- FIGURE 3.SEGMENTATION INTERBODY FUSION CAGES MARKET
- FIGURE 4.TOP INVESTMENT POCKET IN INTERBODY FUSION CAGES MARKET
- FIGURE 5.TOP WINNING STRATEGIES, 2019-2021*
- FIGURE 6.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021(%)
- FIGURE 7.TOP WINNING STRATEGIES, BY COMPANY, 2019-2021*
- FIGURE 8.MODERATE BARGAINING POWER OF BUYERS
- FIGURE 9.MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 10.MODERATE THREAT OF NEW ENTRANTS
- FIGURE 11.LOW THREAT OF SUBSTITUTION
- FIGURE 12.HIGH COMPETITIVE RIVALRY
- FIGURE 13.TOP PLAYER POSITIONING, 2020
- FIGURE 14.MARKET SHARE ANALYSIS, 2020
- FIGURE 15.RESTRAINTS AND DRIVERS: INTERBODY FUSION CAGES MARKET
- FIGURE 16.INTERBODY FUSION CAGES MARKET SEGMENTATION, BY PRODUCT
- FIGURE 17.INTERBODY FUSION CAGES MARKET FOR LUMBAR, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 18.INTERBODY FUSION CAGES MARKET FOR CERVICAL, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 19.INTERBODY FUSION CAGES MARKET FOR THORACO LUMBAR, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 20.INTERBODY FUSION CAGES MARKET FOR THORACIC, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 21.INTERBODY FUSION CAGES MARKET SEGMENTATION, BY SURGERY
- FIGURE 22.INTERBODY FUSION CAGES MARKET FOR ANTERIOR, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 23.INTERBODY FUSION CAGES MARKET FOR TRANSFORAMINAL, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 24.INTERBODY FUSION CAGES MARKET FOR POSTERIOR, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 25.INTERBODY FUSION CAGES MARKET FOR LATERAL, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 26.INTERBODY FUSION CAGES MARKET SEGMENTATION, BY END USER
- FIGURE 27.INTERBODY FUSION CAGES MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 28.INTERBODY FUSION CAGES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 29.INTERBODY FUSION CAGES MARKET FOR OTHERS, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 30.ATOM MEDICAL CORPORATION: NET SALES, 2018-2020 ($MILLION)
- FIGURE 31.ATOM MEDICAL CORPORATION: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 32.ATOM MEDICAL CORPORATION: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 33.AVI HEALTHCARE PVT. LTD: NET SALES, 2018-2020 ($MILLION)
- FIGURE 34.AVI HEALTHCARE PVT. LTD: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 35.AVI HEALTHCARE PVT. LTD: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 36.EQUALIZE HEATH, INC: NET SALES, 2018-2020 ($MILLION)
- FIGURE 37.EQUALIZE HEATH, INC: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 38.EQUALIZE HEATH, INC: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 39.GE HEALTHCARE: NET SALES, 2018-2020 ($MILLION)
- FIGURE 40.GE HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 41.GE HEALTHCARE: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 42.IBIS MEDICAL EQUIPMENT AND SYSTEMS PVT. LTD: NET SALES, 2018-2020 ($MILLION)
- FIGURE 43.IBIS MEDICAL EQUIPMENT AND SYSTEMS PVT. LTD: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 44.IBIS MEDICAL EQUIPMENT AND SYSTEMS PVT. LTD: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 45.NATUS MEDICAL INCORPORATED: NET SALES, 2018-2020 ($MILLION)
- FIGURE 46.NATUS MEDICAL INCORPORATED: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 47.NATUS MEDICAL INCORPORATED: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 48.NINGBO DAVID MEDICAL DEVICE CO. LTD: NET SALES, 2018-2020 ($MILLION)
- FIGURE 49.NINGBO DAVID MEDICAL DEVICE CO. LTD: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 50.NINGBO DAVID MEDICAL DEVICE CO. LTD: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 51.NOVOS MEDICAL DEVICES SAN. TIC. IMP. AND IHR. LTD. STI.: NET SALES, 2018-2020 ($MILLION)
- FIGURE 52.NOVOS MEDICAL DEVICES SAN. TIC. IMP. AND IHR. LTD. STI.: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 53.NOVOS MEDICAL DEVICES SAN. TIC. IMP. AND IHR. LTD. STI.: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 54.WEYER GMBH: NET SALES, 2018-2020 ($MILLION)
- FIGURE 55.WEYER GMBH: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 56.WEYER GMBH: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 57.ZHENGZHOU DISON INSTRUMENT AND METER CO. LTD: NET SALES, 2018-2020 ($MILLION)
- FIGURE 58.ZHENGZHOU DISON INSTRUMENT AND METER CO. LTD: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 59.ZHENGZHOU DISON INSTRUMENT AND METER CO. LTD: REVENUE SHARE, BY REGION, 2020 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook